NCT02687854View on ClinicalTrials.gov

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

CompletedOBSERVATIONAL
Enrollment

18,591

Participants

Timeline

Start Date

February 12, 2016

Primary Completion Date

March 1, 2016

Study Completion Date

March 1, 2016

Conditions
Atrial Fibrillation
Interventions
DRUG

Apixaban

As prescribed by treating physicians

DRUG

Vitamin K antagonist

As prescribed by treating physicians

Trial Locations (1)

Unknown

New York

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT02687854 - Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist | Biotech Hunter | Biotech Hunter